Nicotine Regulates DARPP-32 (Dopamine- and cAMP-Regulated Phosphoprotein of 32 kDa) Phosphorylation at Multiple Sites in Neostriatal Neurons

Nicotinic acetylcholine receptors (nAChRs) regulate dopaminergic signaling in the striatum by modulating the release of neurotransmitters. We have recently reported that nicotine stimulates the release of dopamine via α4β2* nAChRs and/or α7 nAChRs, leading to the regulation of DARPP-32 at Thr34, the site involved in regulation of protein phosphatase-1 (PP-1). In this study, we investigated the regulation of DARPP-32 phosphorylation at its other sites, Thr75 [cyclin-dependent kinase-5 (Cdk5) site], Ser97 (CK2 site), and Ser130 (CK1 site), that serve to modulate Thr34 phosphorylation and dephosphorylation. In neostriatal slices, nicotine (100 μM) increased phosphorylation of DARPP-32 at Ser97 and Ser130 at an early time point (30 s) and decreased phosphorylation of DARPP-32 at Thr75 at a late time point (3 min). The increase in Ser97 and Ser130 phosphorylation was mediated through the release of dopamine via activation of α4β2* nAChRs and α7 nAChRs and the subsequent activation of dopamine D1 and D2 receptors. The decrease in Thr75 phosphorylation was mediated through the release of dopamine via activation of α4β2* nAChRs and the subsequent activation of dopamine D1 receptors. These various actions of nicotine on modulatory sites of phosphorylation would be predicted to result in a synergistic increase in the state of phosphorylation of DARPP-32 at Thr34 and thus would contribute to increased dopamine D1 receptor/DARPP-32 Thr34/PP-1 signaling.

[1]  Angus C Nairn,et al.  DARPP-32: an integrator of neurotransmission. , 2004, Annual review of pharmacology and toxicology.

[2]  Feng Liu,et al.  Mechanism of Regulation of Casein Kinase I Activity by Group I Metabotropic Glutamate Receptors* , 2002, The Journal of Biological Chemistry.

[3]  P. Greengard,et al.  Bidirectional Regulation of DARPP-32 Phosphorylation by Dopamine , 1997, The Journal of Neuroscience.

[4]  D. Kooy,et al.  The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour , 2004, Nature Reviews Neuroscience.

[5]  P. Greengard,et al.  Regulation of DARPP‐32 dephosphorylation at PKA‐ and Cdk5‐sites by NMDA and AMPA receptors: distinct roles of calcineurin and protein phosphatase‐2A , 2002, Journal of neurochemistry.

[6]  P. Greengard,et al.  DARPP-32 mediates serotonergic neurotransmission in the forebrain , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Greengard,et al.  Amplification of dopaminergic signaling by a positive feedback loop. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Greengard,et al.  Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons , 1999, Nature.

[9]  S. Wonnacott,et al.  alpha-bungarotoxin-sensitive nicotinic receptors indirectly modulate [(3)H]dopamine release in rat striatal slices via glutamate release. , 2000, Molecular pharmacology.

[10]  P. Greengard,et al.  Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[11]  P. Calabresi,et al.  Nicotinic excitation of rat ventral tegmental neurones in vitro studied by intracellular recording , 1989, British journal of pharmacology.

[12]  D Cohen,et al.  Phosphorylation of DARPP-32, a Dopamine- and cAMP-regulated Phosphoprotein, by Casein Kinase I in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.

[13]  M. Picciotto Nicotine as a modulator of behavior: beyond the inverted U. , 2003, Trends in pharmacological sciences.

[14]  P. Greengard,et al.  Phosphorylation of DARPP-32, a dopamine- and cAMP-regulated phosphoprotein, by casein kinase II. , 1989, The Journal of biological chemistry.

[15]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[16]  P. Greengard,et al.  Phosphorylation of DARPP-32 and protein phosphatase inhibitor-1 in rat choroid plexus: regulation by factors other than dopamine , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  P. Greengard,et al.  Dopamine- and cAMP-regulated phosphoprotein DARPP-32: phosphorylation of Ser-137 by casein kinase I inhibits dephosphorylation of Thr-34 by calcineurin. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  P. Greengard,et al.  DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein: regional, tissue, and phylogenetic distribution , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  P. Greengard,et al.  Differential regulation of dopamine D1 and D2 signaling by nicotine in neostriatal neurons , 2004, Journal of neurochemistry.